Sea buckthorn oil may help dry eyes, and it has a randomized trial behind it: one randomized, double-blind, placebo-controlled trial of 100 people found that 2 grams a day for three months blunted the seasonal rise in tear film osmolarity in the adjusted analysis and cut the share of people hitting the worst redness and burning scores, though each of those two results held in only one of the two analyses. It did not fix everything, and it is not a replacement for eye care, but the study is real.
Dry eye is miserable, and the supplement shelf is full of promises. Sea buckthorn oil has one randomized, placebo-controlled trial behind it, which is why this page exists and why it sits at the top of the eyes hub. Omega-3 and omega-6 supplements have been tested in 34 trials in a 2019 systematic review, with an uncertain and inconsistent result for long-chain omega-3, so a trial is a start and not an answer. That one trial also lets us tell you precisely what the oil did and did not do, because the researchers measured both.
What the research shows
The Larmo 2010 trial (the one everyone cites)
Researchers in Finland recruited 100 adults with dry-eye symptoms and randomly assigned them to 2 grams of sea buckthorn oil (a blend of seed and berry oil) or a placebo, taken as 1 gram twice daily with meals, for three months from autumn into winter. Winter matters here: cold, dry air naturally worsens tear film osmolarity, the saltiness of your tears that drives the burning and grittiness of dry eye.
Both groups got worse as winter set in, which is exactly what you would expect. But the sea buckthorn group got less worse, and the difference was statistically significant, once the analysis adjusted for baseline osmolarity, baseline Schirmer score and age. Without that adjustment the paper reports no significant difference. Osmolarity was one of four main outcome measures, and the other three, tear break-up time, the Schirmer test and the symptom questionnaire, did not differ:
| Measure | Sea buckthorn group | Placebo group | Significance |
|---|---|---|---|
| Rise in tear film osmolarity | Smaller increase | Larger increase | P = 0.04 (all participants), P = 0.02 (per-protocol), both in the adjusted model |
| Worst redness score reported | 6% of participants | 36% of participants | P = 0.04 (all participants), P = 0.11 (per-protocol, not significant) |
| Worst burning score reported (compliant participants only) | 12% (5 of 43) | 32% (12 of 38) | P = 0.04 (per-protocol), P = 0.05, not significant, when all participants were counted |
| Eye-symptom days (contact-lens wearers only) | 65 ± 29% of days | 81 ± 26% of days | P = 0.049 (all participants), and P = 0.19 among compliers (65% vs 77%, not significant) |
| The other six diary symptoms, tear break-up time, Schirmer test, symptom questionnaire | No significant difference | No significant difference | Not significant |
Read that last row again, because it is the part the marketing pages skip. Of the eight symptoms in the daily diary, the other six showed no significant difference, and neither did tear break-up time, the Schirmer test or the symptom questionnaire. Sea buckthorn did not cure dry eye. It took the edge off the worst of it, for some measures, in one well-run trial.
See the data behind this chart
| Outcome | Placebo | Sea buckthorn oil (2 g/day) | All participants | Compliant participants only |
|---|---|---|---|---|
| Reached the top redness score | 36% | 6% | Significant (P=0.04) | Not significant (P=0.11) |
| Reached the top burning score (compliant participants) | 32% | 12% | Not significant (P=0.05) | Significant (P=0.04) |
The follow-up that complicated the story
In 2011, the same team checked whether the oil worked by changing the fatty acids in the tear film itself. It did not. The changes in tear-film fatty-acid proportions did not differ between the oil and placebo groups (branched-chain P = 0.49, saturated P = 0.59, monounsaturated P = 0.53, polyunsaturated P = 0.16), so the benefit, whatever drives it, does not come from omega-7 simply showing up in your tears. The mechanism is still unknown, and anyone who tells you otherwise is guessing.
How it might work
The trial did not test how the oil might work. The 2011 follow-up, just above, found no difference between the groups in tear-film fatty-acid changes, so the simple “omega-7 lubricates your eyes” story is unlikely. The mechanism is unknown.
What we do not know yet
- Whether results replicate in a second, independent trial (none published so far).
- Whether benefits last after you stop. The trial re-checked people 1 to 2 months after the capsules ended, and among those who took them on at least 80% of days, the osmolarity change from the start no longer differed between the groups.
- Whether berry oil alone works as well as the blend used in the study.
- Whether it helps severe dry eye or only mild to moderate symptoms.
- Whether it reaches the evaporative, meibomian-gland form specifically, since the trial enrolled by symptoms rather than gland imaging.
If you want to try it
The studied approach is 2 grams of a seed-and-berry oil blend daily, split across two meals, for three months. A seed-and-berry blend like the one the trial used is the one in our capsules guide: an 800/200 berry-seed softgel whose maker calls both oils organic, in a kosher gelatin capsule, at about $0.75 to $1.50 a day depending on dose.
One brand aims itself squarely at this use: Membrasin, built around dry eyes and mucous-membrane dryness, with omega-7 printed in milligrams on the maker’s facts panel. Our review likes that transparency, but it also shows the catch, since matching the trial’s 2 grams would take more capsules a day than the maker recommends.
Two cautions. First, berry oil at 5 grams a day showed an antiplatelet effect in a small study, so talk to your doctor first if you take blood thinners or have surgery planned. Second, sea buckthorn is an add-on, not a substitute: keep your artificial tears, your humidifier, and your eye doctor.
The bottom line
For a supplement claim, this one has a real placebo group, 100 participants, a smaller rise in tear osmolarity that held only after adjustment, and two symptom signals, worst redness and worst burning, that each held in only one of the two analyses. It is one trial from one research group. That adds up to one decent trial with a mixed result, promising and not settled, and at about $1.30 to $1.50 a day for the studied 2 grams, it is a reasonable three-month experiment to run with your doctor’s blessing.
The trial, one level deeper
Two details repay attention. First, the winter setting was the test: both groups worsened as cold, dry air pushed tear osmolarity up, and the result was that the oil group worsened less. This was a prevention-of-worsening finding as much as an improvement finding. Second, the statistics: in the adjusted model the osmolarity effect was P = 0.04 across all participants and P = 0.02 among those who took the capsules on at least 80% of days, which is what “per-protocol” meant in this trial. Both clear the conventional bar once adjusted, and neither is so strong that a second trial would not be welcome.
The contact-lens wrinkle
Lens wearers are a dry-eye-prone subgroup, and they were the one group with an extra finding: the share of eye-symptom days was smaller on the oil than on placebo when everyone was counted (65% of days against 81%, P = 0.049, just under the conventional line) but not when only the compliers were counted (65% against 77%, P = 0.19). The oil group’s lens wearers also wore lenses on more days than the placebo group’s, which makes the comparison harder to read. Treat it as a hint from a subgroup rather than a result, and if you wear lenses, keep your lens-care routine and rewetting drops exactly as prescribed while you experiment.
How to raise it with your doctor
Bring the specifics: Larmo and colleagues, Journal of Nutrition, 2010, 100 adults, 2 grams of a seed-and-berry blend daily for three months. Say you want to match that dose, not the label’s single softgel. Mention blood thinners or planned surgery if relevant, because of the antiplatelet signal. And frame it as what it is: an addition to artificial tears and humidifiers, not a replacement. The dry eye trial page covers the methods, the dosage tool translates the 2 grams into products.
Frequently asked questions
Does sea buckthorn oil help dry eyes?
One decent trial points the right way, with a mixed result. In a randomized double-blind trial of 100 people, 2 grams of sea buckthorn oil daily for three months reduced the seasonal worsening of tear film osmolarity once the analysis adjusted for baseline osmolarity, baseline Schirmer score and age. Fewer people on the oil hit the worst redness score when everyone was counted, and fewer hit the worst burning score among those who took the capsules on at least 80% of days, so each of those two results held in only one of the two analyses. Most other symptoms showed no significant difference.
How much sea buckthorn oil should I take for dry eyes?
The trial used 2 grams per day (1 gram twice daily with meals) for three months. That is the dose to discuss with your doctor, not the single softgel many labels suggest.
How long does sea buckthorn oil take to work for dry eyes?
The trial ran three months and measured benefits at the end. Do not expect relief in days. If you try it, give it the full study duration and track your symptoms.
Illustration.